Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials

To estimate the incidence, size, and growth rate of geographic atrophy (GA) during 5 years of follow-up among participants in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Cohort within a clinical trial. Participants included in CATT. A total of 1185 CATT participants...

Full description

Saved in:

Bibliographic Details
Published in:	Ophthalmology (Rochester, Minn.) Vol. 124; no. 1; p. 97
Main Authors:	Grunwald, Juan E, Pistilli, Maxwell, Daniel, Ebenezer, Ying, Gui-Shuang, Pan, Wei, Jaffe, Glenn J, Toth, Cynthia A, Hagstrom, Stephanie A, Maguire, Maureen G, Martin, Daniel F
Format:	Journal Article
Language:	English
Published:	United States 01.01.2017
Subjects:	Aged Aged, 80 and over Angiogenesis Inhibitors - therapeutic use Bevacizumab - therapeutic use Female Fluorescein Angiography Geographic Atrophy - epidemiology Humans Incidence Intravitreal Injections Macular Degeneration - drug therapy Macular Degeneration - pathology Male Middle Aged Multivariate Analysis Prevalence Ranibizumab - therapeutic use Risk Factors
ISSN:	1549-4713, 1549-4713
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!